Alvotech and Teva File for U.S. Biologics License for AVT05, a Proposed Biosimilar to Simponi and Simponi Aria
Exciting News in the World of Biosimilar Medicines Alvotech and Teva Pharmaceuticals Announce FDA Acceptance for Review of Biosimilar BLA Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals have made a groundbreaking announcement that has the potential to revolutionize the way inflammatory conditions are treated. Today, these two biotech giants revealed that the U.S. Food and Drug…